The Clinical Manifestations and Prognostic Factors of Autoimmune-Related Peripheral Corneal Ulcers

Purpose: To investigate clinical manifestations and prognostic factors of autoimmune-related peripheral corneal ulcers. Methods: Nineteen eyes in 18 patients who were diagnosed with autoimmune-related peripheral corneal ulcer from November 1999 to August 2010 were enrolled in the present study. Clinical manifestations and treatment results were investigated retrospectively. Results: The average age at presentation was 64.6 years with female (66.7%) and unilateral (94.4%) dominance. The main etiologies were Mooren’s ulcer (53.6%) and rheumatoid arthritis (26.3%). The ulcer depth was greater than 75% of the corneal thickness in more than half of the cases (57.9%) and the mean extent of the ulcer was 69.5°. There were no significant improvements in visual acuity after treatment ( p = 0.789) and no significant differences in treatment outcomes among etiologies or treatment modalities. The patients who underwent ulcer recurrence ( p = 0.048) or treatment failure ( p = 0.005) had poorer final visual acuity than those patients who did not. The ulcer depth correlated with treatment failure ( p = 0.037). The final visual acuity showed positive correlations with visual acuity at presentation ( p = 0.031) and negative correlations with the number of recurrences ( p = 0.042). Conclusions: The visual acuity at presentation and ulcer depths were significant prognostic factors. These factors appeared to be helpful in the treatment of marginal keratitis depending on the depth of the ulcer.

[1]  S G Coleman,et al.  Transplant Rejection , 2021, Drugs in R&D.

[2]  S. D. Cook,et al.  Rheumatoid Keratolysis: A Series of 40 Eyes , 2006, European journal of ophthalmology.

[3]  Ko-Hua Chen,et al.  Relapsing Mooren's ulcer after amniotic membrane transplantation combined with conjunctival autografting. , 2004, Ophthalmology.

[4]  J. Ladas,et al.  Systemic disorders associated with peripheral corneal ulceration , 2000, Current opinion in ophthalmology.

[5]  Zuguo Liu,et al.  Mooren's ulcer in China: a study of clinical characteristics and treatment , 2000, The British journal of ophthalmology.

[6]  M. Dana,et al.  Twenty-five–Year Panorama of Corneal Immunology: Emerging Concepts in the Immunopathogenesis of Microbial Keratitis, Peripheral Ulcerative Keratitis, and Corneal Transplant Rejection , 2000, Cornea.

[7]  C. Foster,et al.  Vasculitic peripheral ulcerative keratitis. , 1999, Survey of ophthalmology.

[8]  J. Seino,et al.  Mooren's ulcer. , 1998, Optometry and vision science : official publication of the American Academy of Optometry.

[9]  L. Ficker,et al.  The management of corneal perforations associated with rheumatoid arthritis. An analysis of 32 eyes. , 1995, Ophthalmology.

[10]  J. Gottsch,et al.  Autoimmunity to a cornea-associated stromal antigen in patients with Mooren's ulcer. , 1995, Investigative ophthalmology & visual science.

[11]  E. Messmer,et al.  Destructive Corneal and Scleral Disease Associated with Rheumatoid Arthritis: Medical and Surgical Management , 1995, Cornea.

[12]  M. Raizman,et al.  Tectonic Keratoplasty for Peripheral Ulcerative Keratitis , 1991, Cornea.

[13]  S. Lewallen,et al.  Problems with current concepts of the epidemiology of Mooren's corneal ulcer. , 1990, Annals of ophthalmology.

[14]  B J Mondino,et al.  Inflammatory diseases of the peripheral cornea. , 1988, Ophthalmology.

[15]  J. Krachmer,et al.  Conjunctival resection for the treatment of the rheumatoid corneal ulceration. , 1984, Ophthalmology.

[16]  C. Foster,et al.  Tissue adhesive arrests stromal melting in the human cornea. , 1980, American journal of ophthalmology.

[17]  M. Allansmith,et al.  Immunoglobulins in the human cornea. , 1975, American journal of ophthalmology.

[18]  S. Woo,et al.  The Clinical Manifestations of Mooren's Ulcer , 2002 .

[19]  J. Dart,et al.  Lamellar keratoplasty in the management of inflammatory corneal ulceration and perforation , 1994, Eye.

[20]  S. Pflugfelder,et al.  Paracentral rheumatoid corneal ulceration. Clinical features and cyclosporine therapy. , 1992, Ophthalmology.

[21]  T. Hoang‐Xuan,et al.  An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. , 1990, Cornea.